CMTM Proteins in Macrophage: Membrane Trafficking, Immune Checkpoints, and Emerging Roles Across Disease

The CKLF-like MARVEL transmembrane domain-containing (CMTM) family has emerged as a functionally diverse group of membrane-associated regulators involved in receptor stability, vesicular trafficking, and immune homeostasis. Increasing evidence suggests that selected CMTM proteins influence macrophage biology in a context-dependent manner, particularly under conditions of tumor-associated immune suppression, systemic inflammatory stress, and innate immune overactivation. Among the family members implicated to date, CMTM6 is the best-established regulator of programmed death-ligand 1 (PD-L1) stability and thereby contributes to immune evasion in cancer, with emerging evidence suggesting additional effects on macrophage immunoregulatory programming in selected tumor settings. CMTM4 shares partially overlapping activity in PD-L1 regulation, but its macrophage-specific role, especially in sepsis-associated immune dysfunction, remains incompletely defined. In contrast, CMTM7 has been identified as a candidate endogenous negative regulator of macrophage inflammatory activation, functioning through trafficking-dependent control of Toll-like receptor 4 (TLR4) signaling and signal termination. Collectively, current data support a model in which CMTM proteins modulate macrophage responses through membrane-proximal mechanisms governing checkpoint expression, receptor trafficking, inflammatory amplitude, and possibly cell survival. In this review, we summarize current evidence connecting CMTM proteins to macrophage inflammation response in cancer, sepsis, and other inflammatory disease, distinguish established mechanisms from emerging hypotheses, discuss major methodological limitations, and outline priorities for future mechanistic and translational studies.